Observational studyFrontiers in public health2022
Intimate partner violence against ever-partnered women in Europe: Prevalence and associated factors-Results from the violence against women EU-wide survey.
Observational study in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- The association between violence against women and chronic pain: a systematic review and meta-analysis.BMC women's health · 2024Pooled it
- Access to WASH facilities and health implications of period poverty among in-school girls in rural areas of Africa: a scoping review.BMC public health · 2026Article
- Screening tools and programmes for intimate partner violence in antenatal and postpartum healthcare across Europe: a scoping review with quality assessment.BMC pregnancy and childbirth · 2026Article
- Housing for Women in Midlife and Older Who Have Experienced Domestic Violence.Violence against women · 2026Article
- Multilevel analysis of the twelve-month prevalence of intimate partner violence among ever-partnered reproductive-age women in Sub-Saharan Africa: recent DHS data (2019-2024).Archives of public health = Archives belges de sante publique · 2026Article
- The burden and determinants of intimate partner violence against reproductive-age women in four East African countries: evidence from 2021/2023 DHS dataset.Archives of public health = Archives belges de sante publique · 2025Article
- Intimate partner psychological violence and children's sleep difficulties up to 5 years of age: an ELFE birth cohort.European journal of public health · 2025Article
- Spatial variation of intimate partner violence and its public health implication: a cross-sectional study.BMC public health · 2025Article
- Domestic violence and its determinants among reproductive-age women in Sub-saharan Africa: a multilevel analysis of 2019-2024 demographic and health survey data.BMC public health · 2025Article
- Intergenerational 'transmission' of intimate partner violence and abuse: interpretations and implications.The Lancet regional health. Europe · 2025Article
- Reiterated male-to-female violence disrupts hippocampal estrogen receptor β expression, prompting anxiety-like behavior.iScience · 2024Article
- Epigenetics of violence against women: a systematic review of the literature.Environmental epigenetics · 2024Review
- Intimate Partner Violence inInternational journal of environmental research and public health · 2023Review
- Violence against Women and Stress-Related Disorders: Seeking for Associated Epigenetic Signatures, a Pilot Study.Healthcare (Basel, Switzerland) · 2023Article
- Cultural collectivism, intimate partner violence, and women's mental health: An analysis of data from 151 countries.Frontiers in sociology · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study questions: To describe the prevalence of physical, sexual, and psychological intimate partner violence (IPV) against women in the European Union (EU) and to search for their determinants among demographic, socioeconomic, health-related factors, and partner characteristics. Methods: Observational study. Data from the violence against women survey, the first study conducted in the EU, which simultaneously measured all dimensions of IPV and many characteristics. The EU Agency for Fundamental Rights randomly conducted face-to-face interviews among the 28 countries with 42,002 women aged 18-74 who resided in the survey country and spoke the language. IPV is defined by a positive answer to at least one question about physical, sexual, or psychological violence perpetrated by a current or ex-partner. Findings: Among the 40,357 women having already been in a relationship, 51.7% (51.2-52.2) reported having been victims of violence in their lifetime. The prevalence of physical, sexual, and psychological IPV was, respectively, 20.0% (19.6-20.4), 8.4% (8.2-8.7), and 48.5% (48.1-49.0). Women, who were younger, employed, had highly qualified work, had at least one immigrant parent, lived in an urban setting, were unmarried, separated, divorced, widowed, childless, cohabited with a partner, and others over the age of 18, had worse self-perceived health, or a history of violence before the age of 15 were more likely to report IPV. It was the same when their partners had a lower level of education, no work, were home staying, earned less than they did, were involved in 10 years of relationship, were frequently drunk, or were violent otherwise. Major implication: The lifetime prevalence of reported IPV among women in Europe is high and likely underestimated. The results emphasize the importance of a comprehensive definition of IPV and partners' characteristics. They highlight socioeconomic differences and poorer health status for victims of IPV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.